Business · 21/06/2017Updated: 10/17/2026 · 1 min read
Wyeth Pharmaceuticals Inc. et al. Withdraw FDA Approval for 121 New Drug Applications and 161 Abbreviated New Drug Applications
Summary
The FDA is withdrawing approval of 121 new drug applications and 161 abbreviated new drug applications from multiple applicants, following written notifications from the applicants that the drug products are no longer commercially available.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →